Usa covid-19 vaccine patient Usa

COVID-19 Scan for Oct 01, 2021

Reading now: 638
www.cidrap.umn.edu

Remdesivir linked to lower COVID-19 mortalityHospitalized COVID-19 patients who were treated with remdesivir within 2 days of admission had lower mortality rates than their matched cohort, according to a study today in Clinical Infectious Diseases.

The observational cohort consisted of US adults hospitalized with COVID-19 from August to November 2020; 28,855 received remdesivir and 16,887 did not.About 10.6% of patients who received remdesivir died within 14 days, and 15.4% died within 28 days, while those who didn't receive remdesivir had 14- and 28-day mortality rates of 15.4% and 19.1%, respectively.

The researchers estimate that the antiviral drug reduces risk of death by 24% for 14-day mortality and by 11% at 28 days (95% CIs, 0.70 to

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA